Jun 22, 2020
Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir
Jun 17, 2020
Race For Vaccine Intensifies As COVID-19 Second Wave of Outbreaks Threatens
Jun 15, 2020
Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use
May 26, 2020
Emmes Announces its Contribution to NIH ACTT Clinical Trial for Remdesivir
May 20, 2020
Clinical Research and Development Efforts Booming in Midst of COVID-19 Health Crisis
May 19, 2020
COVID-19 Treatments and Vaccine Developments Picking Up Welcomed Pace
May 18, 2020
Enzychem Lifesciences Appoints Duke Medical Coronavirus Task Force Expert Dr. Cameron Wolfe to Lead Development of EC-18 as a COVID-19 Therapeutic Drug
May 13, 2020
Hetero Enters Into a Licensing Agreement With Gilead Sciences, Inc. for the Manufacturing and Distribution of "Remdesivir" in 127 Countries, Including India, for COVID-19
May 12, 2020
Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19
May 01, 2020
Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
Apr 27, 2020
Romark Initiates Phase 3 Clinical Trials Of NT-300 For COVID-19
Apr 23, 2020
Scientists Worldwide Feverishly Working to Develop New Drug and Vaccine Candidates for COVID-19 Crisis
Apr 14, 2020
Growing Number of Coronavirus Vaccines Under Development With 3 in Human Trials
Apr 08, 2020
Biotechs Fast Track Repurposing Existing Drugs for COVID-19 Treatments
Apr 07, 2020
FDA Accelerates Development of Novel Therapies for COVID-19
Apr 01, 2020
Oracle Therapeutic Learning System Records Effectiveness of COVID-19 Drugs
Mar 26, 2020
Innoplexus Announces Major Findings in Potential Combination Therapies for COVID-19
Mar 20, 2020
University Hospitals among first in nation to test investigational antiviral drug against COVID-19
Mar 19, 2020
Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments